Biological therapy

Cards (11)

  • How do we treat schizophrenia if it has a biological basis?
    • Most common treatment of schizophrenia involves typical or atypical antipsychotic drugs in the form of tablets, syrups, or injections - can be taken long term or short-term
  • What are typical antipsychotics? (1950s)
    • Dopamine antagonists block dopamine receptors in the synapses of the brain and have a sedative effect on patients. These bind to but do not stimulate dopamine receptors which blocks their action, therefore normalising neurotransmission in key areas of the brain and reducing positive symptoms
    • An example of chlorpromazine which is often used to calm anxious patients admitted to the hospital, maximum dosage for most people is around 400-800mg
  • What are some side effects of typical antipsychotics?
    • Chlorpromazine is an effective sedative, related to its effect on histamine receptors
    • Extrapyramidal symptoms in sudden movement, weight gain, blurred vision
    • Can lead to loss of menstrual periods for women
  • What are atypical antipsychotics? (1970s)
    • These still block D2 receptors but only temporarily occupy them, before rapidly dissociating to allow for normal dopamine transmission.
    • They also influence serotonin receptors as well as dopamine, which may contribute to their ability to address both positive and negative symptoms of schizophrenia
  • What is clozapine?
    • Developed in the 1960s, binds to dopamine receptors in the same way as chlorpromazine but additionally acts on serotonin and glutamate receptors, believed to help improve mood and cognitive functioning
    • Mood-enhancing effects means it is sometimes prescribed for people at a high risk of suicide
    • During early trials it turned out to be fatal for people with a blood condition called agranulocytosis, however people using it today have regular blood tests to ensure they don't have this
  • What is risperidone?
    • More recently developed atypical antipsychotic that binds more strongly dopamine receptors as well as serotonin receptors, and is therefore effective in much smaller doses than most antipsychotics
    • Is evidenced to lead to fewer side effects
    • Typical daily dose is around 4-8mg and lasts for up to 2 weeks
  • What are the differences between typical and atypical antipsychotics?
    • Atypical psychotics tend not to affect the dopamine systems that control movement, carrying a lower risk of extrapyramidal side effects
    • Due to blocking serotonin receptors on top of dopamine they can also benefit negative symptoms as well as cognitive impairments
    • Atypicals can be administered through injections making them suitable for treatment-resistant patients
    • Block D2 receptors for a short period of time, typicals block them for longer
  • What is one strength of drug therapy for schizophrenia?
    • Research support for effectiveness: Thornley et al. (2003) reviewed studies comparing the effects oh chlorpromazine to placebos -> data from 13 trials concluded that chlorpromazine was associated with better overall functioning and reduced symptom severity
    • Meltzer (2012) concluded that clozapine is effective in 30-50% of treatment-resistant cases where typical antipsychotics failed
    • Suggests that as far as we can tell antipsychotics work
  • What is one limitation of drug therapy for schizophrenia?
    • Exaggerated evidence: Healy (2012) has suggested serious flaws with evidence for effectiveness as most studies only cover short-term effects and the successful ones have been published multiple times, showing an exaggeration of positive effects
    • Because they have powerful calming effects it is easy to demonstrate that they have a positive effect yet this does not equate to reducing the overall severity of their symptoms
    • Suggests the effectiveness of drugs may not be what it seems
  • What is another limitation of drug therapy?
    • Serious side-effects: include dizziness, itchiness, weight gain, sleepiness, agitation
    • Long-term use can lead to tardive dyskinesia, characterised by involuntary facial movements like lip-smacking due to dopamine supersensitivity
    • Can also lead to neuroleptic malignant syndrome - when the drug blocks dopaminergic activity in the hypothalamus it can result in high temperature, delirium, comas, can even be fatal
    • May lead to individuals avoiding the treatment altogether, limiting its actual effectiveness
  • What is another limitation of drug therapy?
    • Mechanisms unclear: our understanding of atypical and typical drugs are based off of the original dopamine hypothesis which claims that positive symptoms are linked to excess DA
    • BUT the updated hypothesis suggests some symptoms are the results of low dopamine in the brain's cortical regions
    • According to our knowledge most antipsychotics shouldn't work as there are contrasting claims, questioning the effectiveness of the treatment if its' mechanisms is ambiguous and unclear